Here is the latest stock price and chart of Natco Pharma. For more details, see the Natco Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Get Details: These 3 Stocks are the Dark Horses of the Stock Market
Live BSE Quotes | Jan 15, 2021 (Close) | ||
---|---|---|---|
Price (Rs)917.05 | Open (Rs) 941.30 | High (Rs) 949.10 | Low (Rs) 903.25 |
% Change-2.16 | Volume 32,477 | Value (Rs) 29,985,659 | 52-Week H/L 995.05 / 450.00 |
Live NSE Quotes | Jan 15, 2021 (Close) | ||
---|---|---|---|
Price (Rs)916.60 | Open (Rs) 941.50 | High (Rs) 944.90 | Low (Rs) 903.00 |
% Change-2.17 | Volume 355,432 | Value (Rs) 325,788,971 | 52-Week H/L 996.00 / 402.55 |
Change | |||||
---|---|---|---|---|---|
1 Day -2.16% | 1 Month -3.12% | 3 Months 4.60% | 1 Year 47.41% | 5 Years (CAGR)* 11.57% | 10 Years (CAGR)* 32.14% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 26.33 | P/E Ratio (x) 34.83 | Market Cap (Rs m) 152,367.86 | P/BV (x) 4.95 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
NATCO PHARMA last traded price was down 2.2% to Rs 917.1 on the BSE. On the NSE, NATCO PHARMA last traded price was down 2.2% to Rs 916.6. The total volume of shares traded was 0.4 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.2%. And the benchmark S&P BSE SENSEX was at 49,034.7 (down 1.1%).
Over the last 30 days, the NATCO PHARMA share price is down 4.0%. And over the last one year, NATCO PHARMA share price is up 45.3%.
What else is happening in the markets today? Dig in...
Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.
For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.
For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.
More Views on NewsMy new guide will show you the huge potential in future proof businesses.
The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
Ajit Dayal on the investing strategy for 2021 and beyond.
More